1 active not recruiting, 1 recruiting, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Recruiting 1, Unknown 1 |
Follow Medullary Thyroid Cancer: new trials by email Literature Review of Medullary Thyroid Cancer trials Research Report on Medullary Thyroid Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma Anlotinib Hydrochloride Capsule - Medullary Thyroid Cancer | Phase 4 | Recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 360 | 2023-06-19 | 2023-07-25 |
| A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer Cabozantinib (XL184) 140 mg, Cabozantinib (XL184) 60 mg, Placebo tablet - Medullary Thyroid Cancer | Phase 4 | Active not recruiting | Exelixis | 247 | 2015-02-25 | 2026-10-20 |
| Radiolabeled Molecules for Medullary Thyroid Cancer Lu 177 - Medullary Thyroid Cancer | Phase 4 | Unknown | Instituto Nacional de Cancer, Brazil | 20 | 2013-08-01 | 2016-09-07 |
Carcinoma, Medullary (3) · Thyroid Neoplasms (1)
Adenocarcinoma (3) · Carcinoma (3) · Carcinoma, Neuroendocrine (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Ductal, Lobular, and Medullary (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Neuroendocrine Tumors (3) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Head and Neck Neoplasms (1) · Neoplasms by Site (1)
Lutetium-177 (1) · cabozantinib (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Exelixis (1) · Instituto Nacional de Cancer, Brazil (1)
Australia (1) · Brazil (1) · Canada (1) · China (1) · Croatia (1) · France (1) · Hungary (1) · Israel (1) · Italy (1) · Netherlands (1) · Poland (1) · Romania (1) · Russia (1) · South Korea (1) · Spain (1)